Endometrial carcinosarcoma (ECS) is a rare, highly aggressive disease characterised by a biphasic growth of malignant epithelial (carcinomatous) and mesenchymal (sarcomatous) components. Clinically, it cannot be distinguished from endometrial carcinoma or uterine sarcoma. The definitive diagnosis can only be made based on histological examination and immunohistochemistry. To date, there aren't standardised treatment protocols for its management. We report a case of a 73-year-old patient who presented postmenopausal abnormal uterine bleeding and was diagnosed with ECS. A non-conventional treatment approach was conducted with favourable oncological outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9934871PMC
http://dx.doi.org/10.3332/ecancer.2022.1472DOI Listing

Publication Analysis

Top Keywords

endometrial carcinosarcoma
8
carcinosarcoma poor
4
poor prognosis
4
prognosis debut
4
debut favourable
4
favourable therapeutic
4
therapeutic outcome
4
outcome endometrial
4
carcinosarcoma ecs
4
ecs rare
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!